CD8A and neoplasm: Secondly, there are other types of immune cells beyond CD8+ T cells that have been demonstrated to have predictive power in patient prognosis, such as tumor-associated macrophages (Zhang et al., 2012) as well as Tregs (Shang et al., 2015).